600196.SS Stock Analysis
60
Uncovered
Shanghai Fosun Pharmaceutical Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Market cap $B
7.802
Dividend yield
2.92 %
Shares outstanding
2 672.16 B
Website
https://www.fosunpharma.com/Shanghai Fosun Pharmaceutical Group Co Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Shanghai, Shanghai and currently employs 36,279 full-time employees. Shanghai Fosun Pharmaceutical (Group) Co., Ltd. is a China-based company, principally engaged in the research and development, production and distribution of pharmaceuticals. The firm's products are mainly applied in the treatment of metabolism and digestive tract system, cardiovascular system, central nervous system, blood system, anti-tumor and anti-infection diseases. The firm is also engaged in medical equipment and medical diagnosis business, as well as the provision of medical services. The company distributes its products primarily in domestic and overseas markets.